Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2018

Effectiveness of Continuous Subcutaneous Insulin
Infusion Therapy Education in a Clinic Setting
Kimberly Rizzo
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Educational Assessment, Evaluation, and Research Commons, and the Nursing
Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.

Walden University
College of Health Sciences

This is to certify that the doctoral study by

Kimberly Rizzo

has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.

Review Committee
Dr. Janice Long, Committee Chairperson, Nursing Faculty
Dr. Lilo Fink, Committee Member, Nursing Faculty
Dr. Deborah Lewis, University Reviewer, Nursing Faculty

Chief Academic Officer
Eric Riedel, Ph.D.

Walden University
2018

Abstract
Effectiveness of Continuous Subcutaneous Insulin Infusion Therapy Education in a
Clinic Setting
by
Kimberly Ann Rizzo

MS, Walden University, 2015
BS, University of Michigan, 2012

Project Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Nursing Practice

Walden University
July 2018

Abstract
Diabetes affects an estimated 29.1 million Americans, with approximately another 1/3 of
Americans not yet diagnosed. Complications associated with diabetes include heart
disease, stroke, hypertension, blindness, kidney disease, neuropathy and death. All of
these complications can be prevented with optimal control of blood glucose levels.
Advances in technology provide people living with diabetes (PLWD) a multitude of
treatment options such as continuous subcutaneous insulin infusion (CSII) therapy.
Unfortunately, sustained improvement in glycated hemoglobin A1c (HgA1c) is not
always achieved even with this advanced therapy. The purpose of this doctoral project
was to educate nurses on CSII therapy and promote improved patient compliance,
knowledge and ultimately improve HgA1c control. This doctoral project is an evaluation
of an Evidence-Based Quality Improvement Project (EB-QIP) that evaluated nurse-led
educational sessions for PLWD using CSII therapy. The integrated theory of health
behavior change was used to guide the project. The CDC process evaluation model was
used to evaluate the outcomes of the education sessions. Results showed that patients
who were instructed by the nurses who took part in the EB-QIP had a reduction in the
overall HgA1c by an average of 1.1 points 3-months post-education. The project
promotes positive social change through establishing the effectiveness of an EB-QIP that
focused on the use of education on CSII therapy in improving outcomes for patients
living with diabetes.
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Section 1: Nature of the Project
Introduction
Type 1 and Type 2 diabetes are chronic conditions that have experienced
exponential growth worldwide (Rowley & Bezold, 2012). The prevalence of diabetes has
increased in the United States, from 1.6 million in 1958, accounting for 0.9% of the
population, to 23.4 million in 2015, accounting for 7.4% (CDC, 2017). The United States
has become the epicenter of “supersized” with the explosion of fast food and subsequent
rise in obesity (Spurlock & Spurlock, 2004). This, in addition to sedentary lifestyles, has
led to the dramatic increase in diabetes and other associated chronic health conditions. In
the United States, the prevalence of diabetes among the adult population ranges between
5.8% and 12.9%, accounting for approximately 14% of all health care expenditures, or
$245 billion (McCulloch, 2016).
Type 2 diabetes (T2D) is expected to increase approximately 64%, from 19.1 to
53.1 million, by 2025 (Rowley & Bezold, 2012); worldwide T2D is expected to increase
to approximately 415 million, with an annual economic impact close to $500 billion. The
United States spends nearly double in health care expenses per capita compared to
countries such as Germany, Canada, Denmark and France (Zhang et al., 2010). The
increasing cost of treating chronic diseases such as diabetes is causing an economic crisis
in the United States. The economic backlash is not only hurting the United States fiscal
pocketbook but is becoming a financial hardship for individuals and families. The cost of
annual health insurance premiums for the average American family ($17,545) is close to
the gross yearly income of a full-time minimum wage worker, (KFF, 2015).
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Without sustained HgA1c normalization, complications are likely, such as
cardiovascular/cerebrovascular disease, renal impairment, retinopathy, and peripheral
neuropathy (McCulloch, 2016). These complications can present silently until end-organ
or vessel damage manifests. With the traditional use of multiple daily injections of insulin
that are required to promote optimized glycemic control, personal compliance is critical.
Multiple daily injection (MDI) therapy requires approximately 5 to 6 injections daily,
along with frequent finger pricks to monitor blood glucose levels (Mayo Clinic, 2017).
Also, MDI therapy brings with it a high risk of hypoglycemia, as exogenous insulin has a
slower rate of absorption when compared to the normal physiology of the pancreas in a
person who is nondiabetic (McCulloch, 2016).
Modern medicine, especially technological advances and treatment modalities,
has experienced remarkable advances. Continuous subcutaneous insulin infusion (CSII)
therapy, also known as insulin pump therapy, has greatly improved the quality of life for
many people living with diabetes requiring insulin therapy. As this therapy was designed
to improve glycated hemoglobin (HgA1c) levels in people living with diabetes (PLWD)
requiring insulin therapy, it is becoming evident that this reduction is only short-term, as
HgA1c levels over time begin to increase (Nixon, Folwell, &Pickup, 2014). The increase
in HgA1c levels may be associated with knowledge deficiency, poor patient compliance
with the use of this sophisticated technology, a lack of sufficient patient education
focusing on CSII technology, or the interaction between the patient and health care
provider (Nixon, Folwell, & Pickup, 2014). As the tasks related to CSII technology can
be quite intricate, basic functions are the focus of the training when CSII therapy is
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initiated, leaving PLWD lacking a more in-depth understanding of the use of their insulin
delivery system. So, the decline in HgA1c levels after initiation of CSII therapy may be
not be linked solely to one cause, but a combination of many causes.
The purpose of this doctoral project was to evaluate the outcomes of a quality
improvement project (QIP) specific to PLWD using CSII therapy. The QIP consisted of
three 45-minute education sessions to improve the knowledge and the confidence of
PLWD in engaging in self-management to stabilize HgA1c levels. Secondary,
deidentified data, was used to determine the effectiveness of the QIP and included
aggregate serum HgA1c levels prior to initiation of the QIP and aggregate serum HgA1c
levels three months post QIP.
Local Context for Gap-In-Practice
Breakthroughs in technology, such as CSII therapy, are changing how PLWD
manage this disease. Although the CSII technology will not reduce the number of PLWD,
the complications related to diabetes can be minimized. The research specific to the
effectiveness of CSII therapy is mixed, however. Bode (2010) posits achieving maximum
CSII therapy effectiveness requires continued patient education, in addition to the
traditional cross-sectional and basic education received at the initiation of CSII therapy.
Without tailored longitudinal guidance to learn strategies for glycemic control
(Bergenstal et al., 2013), the typical PLWD will not realize the benefits offered by the
CSII technology.
CSII technology provides different data entry options that are person-specific.
This facilitates the insulin that mimics the function of pancreas, delivering both basal and
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bolus insulin. Without understanding the basic-level options through experience and
continued education, the more advanced tasks available with the CSII technology are not
realized. As Bergenstal et al. (2013) explain, the knowledge deficit reduces the ability of
a provider to collaborate with the PLWD to make safe clinical decisions when adjusting
CSII data.
According to Bergenstal et al. (2013), analysis and visualization of pertinent
standardized glucose data by providers also plays a contributing role in poor glycemic
control among CSII users. Analysis of the data provided by the CSII device is critical in
calculating appropriate insulin administration. This data weighs heavily on the precise
computation of insulin needs, carbohydrate intake, sleep/wake cycles, and glucose levels.
To program the CSII technology to deliver the correct insulin, the provider must have
expert knowledge in analyzing what is visualized on the charts and graphs that are
furnished with each CSII download (Medtronic, 2009). This knowledge, although not
expert, should be understood by the user of the CSII technology at least minimally to
recognize the importance of correct data input. This is a vital reason patient education is
so relevant in optimizing glycemic control.
Local Relevance.
The State of Arizona has a population of 1,796,000, with 682,071 diagnosed with
diabetes, which is 12.5% of the adult population (American Diabetes Association [ADA],
2015). Prediabetes, higher than normal blood glucose levels (70 – 100), accounts for
37.5% of the adult population, with an estimated 34,000 newly-diagnosed diabetics in
Arizona yearly (ADA, 2015). Between 1995 and 2010, there was an 80% increase in
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people diagnosed with diabetes in Arizona, while it is theorized that one-third remain
undiagnosed (Humble & Tormala, 2011). In 2011, there were 390,000 people in Arizona
reported to have diabetes (Humble & Tormala, 2011); four years later the diabetic
population almost doubled to the estimated 682,071 people diagnosed with diabetes in
Arizona (ADA, 2015). An estimation of those undiagnosed in the State of Arizona is
172,000 (ADA, 2016).
In 2006, there were 1,755 per 100,00 diabetes-related hospitalizations in Arizona,
accounting for 170 more hospitalizations than other Western states (Humble & Tormala).
The total direct medical expenses associated with treatment of diabetes in the State of
Arizona was estimated at $4.9 billion in 2012, with an additional $1.5 billion for indirect
costs associated with diabetes. Nationally, the total estimated cost associated with the
diagnosis of diabetes in 2012 is $245 billion; $176 billion in direct medical costs and $69
billion in indirect costs. Reported costs associated with diabetes prevention and
education in the State of Arizona in 2016 provided by the Division of Diabetes
Translation at the Centers for Disease Control and Prevention (CDC) was $1,941,335. In
2015, the National Institute of Diabetes and Digestive and Kidney Diseases at the
National Institute of Health provided funding in the amount of $10,085,465 to be used for
research projects specific to diabetes in the State of Arizona (ADA, 2016).
The Diabetes Clinic (a pseudonym) is located in a large southwestern state with a
patient population consisting of Native-Americans, Hispanics, Asians, non-Hispanic
Whites, and African-Americans. Diabetes statistics vary across the ethnic groups. For
example, diabetes affects approximately 16.1% in the Native-American population,
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followed by 12.6% of African-Americans, 8.4% Asians, 11.8% Hispanics, and 7.1% nonHispanic whites (Humble & Tormala, 2011). According to the Center for Disease Control
and Prevention (CDC) Report in 2011, the Native-American community in Arizona
accounts for 5% of the population at approximately 319,600 people.
Worldwide, 415 million people have been diagnosed with diabetes, in addition to
an estimated 193 million people that are either unaware of being diabetic or have not yet
been diagnosed (Chatterjee, Khunti & Davies, 2017). In 2015, diabetes was placed as the
sixth-leading cause of disability, creating a global economic burden estimated at $825
billion (Chatterjee, Khunti & Davies, 2017). In the United States, the economic burden of
managing diabetes is approximately $245 billion yearly (CDC, 2014). Improving diabetes
care with the promotion of CSII therapy in PLWD is paramount for decreasing the
chronicity of diabetes and its complications.
Significance to Nursing
Health care is advancing in the United States, offering nurses more active roles in
improving patient care through implementing evidence-based practices. Nurse-led
education has become important in chronic disease management (Levich, 2011). Specific
to diabetes, nurses can positively impact social change with respect to increasing the
effectiveness of insulin therapy by reducing knowledge deficits and increasing selfmanagement skills (Levich, 2011).
Inadequate management of diabetes can lead to increased complications,
decreased quality of life, and large financial expenditures. By 2020, chronic diseases will
account for an estimated three-quarters of the disease burden globally, consisting of an
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estimated 60% from diabetes alone, specifically T2D and cardiovascular disease. (Day &
Brown, 2014). With the chronic disease burden growing, nurses are ideally positioned in
organizations and educationally prepared to provide the necessary longitudinal education
to advance self-management skills by decreasing the knowledge deficit.
According to Levich (2011), nurses should lead the agenda to engage in long-term
person-specific education to enhance the management of PLWD using CSII technology.
This project is particularly important as nurses need to also engage in outcomes
evaluations for their work. For PLWD using CSII therapy for glycemic control, a nurseled education program can potentially increase experiential knowledge through the use of
technology and increase self-management by reducing knowledge deficits. The purpose
of this doctoral project was to evaluate the impact a nurse-led education program has on
improving the knowledge deficit and self-management of diabetes.
Purpose Statement
Gap-in-Practice
For PLWD, CSII therapy provides a convenient, targeted, and tailored means for
timely insulin infusions to rapidly respond to changes in blood glucose levels. However,
there is a gap in nursing practice specific to knowledge deficits when PLWD utilize the
treatment modality and achieve suboptimal reductions in HgA1c levels. Jayasekara,
Munn, and Lockwood (2011) found that PLWD need continued education and training
with comprehensive advice by experts to successfully use CSII therapy. Wu et al. (2013)
reported that, with continued education and training by skilled professionals, PLWD had
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significant reductions in HgA1c levels (p < 0.001), improvements in self-efficacy (p
<0.001), and increased self-care (p <0.001).
The purpose of this doctoral project was to evaluate the impact of a nurse-led
education program on glycemic control for PLWD using CSII technology. The nurse-led
education program consisted of three 45-minute sessions focused on advanced
technological training specific to CSII therapy, and the development of self-management
skills. The hypothesis was that effective multi-session education can reduce knowledge
deficits, improve self-efficacy, and promote self-management. The increased use of CSII
therapy for intensive insulin treatment for PLWD is an appropriate option for many;
however, not every PLWD is a good candidate for this treatment modality. With
technological advancements it is imperative that the appropriate education, geared toward
specific patient populations, be designed to promote the best possible outcome. Use of
CSII therapy in PLWD over the next decade is expected to double, according to Saboo
and Talaviya (2012). This expected growth should prompt the medical community to
enhance the use of CSII therapy with extended educational sessions that promote selfmanagement skills along with improving knowledge deficits correlated with the correct
use of CSII technology.
There is inconsistent success with CSII therapy reported in the literature as
demonstrated by Chamberlain and Gilgen (2014), who conducted a single-arm study that
included 16 T1D and 12 T2D, concluding that patients’ perceptions of the usability of
CSII technology greatly affected the success of the therapy. The OpT2mise RCT study
suggested that there was much greater variability in the T2D population versus the T1D
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population (Aronson et al., 2014). Conget et al. (2016) performed a follow-up study that
concluded suboptimal controlled T2D had significant improvement in HgA1c levels with
the use of CSII therapy. Seven contributory factors were identified, including:
1. Patient tolerance and/or intolerance to insulin and therapy;
2. Biological changes to the patient resulting from age and/or gender;
3. Endocrine system function;
4. Patient lifestyle and stress levels;
5. Provider interaction and/or monitoring intervals;
6. Sensory-Augmented Pump Therapy (SAPT); and.
7. CSII technological shortfalls.
On quarterly follow-up assessments of PLWD utilizing CSII therapy at the
diabetic clinic, systematic CSII (insulin pump) downloads are performed to evaluate data
that is input into the insulin pump by the individual using the CSII therapy. This data is
then used to calculate insulin pump settings in an effort to optimize disbursement of
insulin and regulation of blood glucose levels. It has been identified, through the review
of reports generated from the insulin pump download, that consistent blood glucose
monitoring is suboptimal in many instances. Blood glucose monitoring should be
performed a minimum of 4 times daily, however, ideal monitoring consists of 5 to 6
times daily for CSII therapy optimization (Mayo Clinic, 2017). CSII technology provides
several reports generated through patient interaction with the insulin pump offering
specific identifying factors that will alert the provider of inadequate use of CSII
technology. Although CSII therapy promises to provide tighter glucose levels, thus
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improving patient outcomes, the technology is changing so rapidly that it is theorized that
PLWD and providers lack the up-to-date knowledge to optimize it.
Evidence-Based Health Care
Evidence-based health care formulates and implements treatment plans based on
current knowledge derived from evidence-based research and expert opinion. The intent
is to deliver safe, effective care that is patient-specific and promotes positive outcomes.
The evidence-based health care approach incorporates problem-solving with the most
current evidence from peer-reviewed research studies, along with advice from a
knowledgeable clinician, and considers values and preferences of the patient (FineoutOverholt, Melnyk, Schultz, 2005). Through a patient-centered, evidence-based approach
to the management of diabetes, Tricco et al. (2012) found improvement in the
management of diabetes through quality improvement (QI) strategies. The strategies that
supported the greatest improvement in HgA1c levels were patient education and the
promotion of self-management skills guided by health-care professionals (Tricco et al.,
2012). Tricco et al. (2012) demonstrated that, by implementing evidence-based health
care in the design of interventions that focused on quality indicators, HgA1c levels
improved; however, when QI strategies focused on targeting both health systems and
patients, there was even greater improvement in HgA1c levels.
PICOT Process
A well-designed EB-QIP begins with recognizing a clinical problem, or situation
that can be positively changed and/or be improved upon. By structuring a question that
specifically defines the problem, evidence-based practice can be implemented using a
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problem-solving approach to the situation (Fineout-Overholt, Melnyk, & Schultz, 2005).
The PICOT question is a formula designed for nurses to easily categorize the components
necessary in defining the clinical problem, allowing for strategic organization of details
and the formulation of a structured problem statement. Through the PICOT process, the
nurse is able to gather appropriate research evidence and evaluate the evidence before
implementing it into practice. Through the evaluation process, interventions will be
applied that best fit the clinical problem and the problem statement. Interventions are
developed that best fit the population affected, problem identified, and place in which the
intervention will be implemented. Evidence-based research is employed in this process to
promote improved patient outcomes.
Guiding Practice Focused Question
How will nurse-led educational sessions for PLWD using CSII therapy impact
knowledge deficit and HgA1c levels?
Response to the Gap-in-Practice
CSII therapy, otherwise known as insulin pump therapy, has been in use for over
50 years (American Association of Diabetes Educators [AADE], 2014). According to the
AADE (2014), CSII therapy provides improved quality of life with a less restricted
lifestyle, along with improvement in glycemic control. The success of CSII therapy is
determinant on careful assessment of PLWD, including physical and psychological
factors that are key features in identifying a person’s ability to successfully overcome the
challenges of insulin pump technology (AADE, 2014).
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The technology of CSII therapy can be very intricate and difficult to understand,
especially for the novice. Also, at the initiation of CSII therapy, many features of the
insulin pump are reviewed, which can be daunting for many people. There appears to be
a gap in the depth of knowledge and use of CSII therapy for PLWD utilizing this
treatment modality. This has become evident in the reports that are generated through the
database of each insulin pump at the diabetes clinic identifying noticeable gaps in data.
The information provided by the insulin pump allows the clinician to view daily
interaction with the insulin pump by the user, recognizing gaps in proper operation.
CSII therapy provides continuous insulin infusion that is set by a provider
delivering basal insulin throughout the day (Saboo. & Talaviya, 2012). However, as
recognized by the AADE (2014), patients have the responsibility of routinely checking
blood glucose levels to promote glycemic control. When there is missing information,
such as blood glucose levels and carbohydrate values, safe adjustments to the insulin
pump cannot be made, thus poor glycemic control continues. CSII therapy is only as
good as the user’s ability to furnish the appropriate information and enter it into the
insulin pump.
Nature of the DNP Project
Project Sources of Evidence
The evidence to support this program evaluation was derived from a secondary
data analysis consisting of aggregate serum HgA1c values 3 months prior to the initiation
of the QIP and 3 months after the conclusion of the QIP, along with secondary data
extracted from the Adherence Reports relevant to the evaluation. This secondary data was
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made available from the diabetes clinic for the evaluation of the QIP. No identifying
patient information was made available to the Doctoral Student performing the
evaluation.
Project Method
All participants in the QIP were PLWD requiring insulin through CSII therapy
and were patients at the diabetic clinic where the QIP took place. This is an evaluation of
patient educational sessions. Mandatory participation in three 45-minute educational
sessions was determined to be appropriate in gathering necessary information for the
evaluation. Each educational session was participant-specific, identifying areas of need
for advanced training in CSII therapy through review of the participant’s insulin pump
download reports with each session. Behavioral data located on the Adherence Report
was provided by the site to the evaluator (the DNP student) void of any participant
identifying information upon evaluation of the QIP, allowing for a detailed understanding
of the participant’s adherence according to indices of glucose measurements, bolus
events, and insulin pump activities (Medtronic, 2009).
Each session began with review of the previous sessions’ learning objectives and
continued with further education about each category in the Adherence Reports. This
selective focus on each category provided the participants a closer observation of their
own behaviors regarding the use of their insulin pump and how their behavioral data
affected their blood glucose levels. Participants were provided detailed educational
packets that recapped the material covered with each session. Each participant was
educated on all categories of the insulin pump reports to become familiar with the data
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derived from the download, and the importance of this data in the improvement of
glycemic control. All participants participated in three sessions.
Project Pathway
The purpose of this doctoral project was to evaluate the outcomes of an
educational program specific to PLWD using CSII therapy in a diabetic clinic, and to
identify whether advanced education would provide improvement in HgA1c levels and
self- management skills focal to CSII use.
Significance
Improved clinical outcomes for PLWD are achieved with stabile maintenance of
normal to near-normal glycemic control (Pozzilli et al., 2016). There are many factors
that affect normal to near-normal glycemic control. It was the purpose of this project to
identify these factors, and to evaluate the impact of education on HgA1c and compliance.
Without normalization of blood glucose levels, chronic conditions can manifest, such as
diabetic peripheral neuropathy and diabetic retinopathy. Grenell and Turner (2016)
estimated 47% of patients with diabetes will eventually develop peripheral neuropathy.
Approximately 50% to 75% of non-traumatic amputations are related to diabetic
peripheral neuropathy (Grenell & Turner, 2016). This project will analyze the outcomes
of an EB-QIP aimed to increase the knowledge and skills of the PLWD in the managing
glycemic control with CSII therapy.
Stakeholder Analysis
The most evident stakeholders in this process were PLWD utilizing CSII therapy;
however, the director of the clinic, as well as the nurse practitioners that provide care to

15
the patients at the clinic were contributing stakeholders, in that their depth of
understanding the technology of CSII therapy would promote improved patient
outcomes. Family and friends of PLWD utilizing CSII therapy were also stakeholders, in
that, through their continued support and encouragement, they could positively advocate
for the advancement of knowledge needed to continue to improve lifestyle and overall
health.
It is evident in the literature that, with the normalization of HgA1c and reduction
in the variability of glucose levels, a decline in the complications associated with diabetes
i.e., microvascular and macrovascular should be seen. The incidence of lower limb
amputations is 46.1 to 9600 per 105 (Moxey et al., 2011); the Diabetes Control and
Complications Trial DCCT/Epidemiology of Diabetes Interventions and Complications
(EDIC) study found that intensive glycemic control reduced fatal and nonfatal
cardiovascular disease and stroke by 57 percent (McCulloch, 2016). The reductions in
these catastrophic complications would lead to less time off of work, overall improved
health and wellness, and economic status for PLWD.
Quality of life for PLWD and their family members would improve with the
decrease in complications associated with diabetes. Adriaanse et al. (2015) found that
maintaining a good quality of life is a pertinent goal to be set with T2D, in that it
improves a person’s perspective about their well-being socially, physically and mentally.
The complications associated with diabetes grossly determine the quality of life in PLWD
(Adriaanse et al., 2015).
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Family members often care for loved ones with chronic illness and, with reforms
in the U.S. health care system, this is becoming more progressive over time (Lim &
Zebrack, 2004). Lim & Zebrack (2004) found through a literature review that, when
caregivers experienced stress caring for a family member, this equated to the caregiver
appraising themselves as lacking in self-efficacy, creating high levels of caregiver
depression. With reduction in HgA1c levels in PLWD, chronic conditions and
complications from diabetes can be prevented, alleviating family members from caring
for a chronically ill loved one.
The diabetic clinic that performed the QIP, dependent on the evaluation, may
experience a positive impact from addressing this local problem. Uncontrolled diabetes,
as discussed previously, is associated with a number of chronic conditions associated
with the neurovascular, cardiovascular, and renal systems. An increase in patient
population may be experienced related to the positive outcomes the participants
experience, lending to primary care providers referring more patients to the clinic for
treatment of diabetes.
Contributions to Nursing Practice
This doctoral project promotes continued evidence-based projects and translation
of evidence to stimulate continued education for diabetes and chronic disease states. This
project was geared to identify the gap not only in practice, but in the significance of
nursing’s role in the translation of evidence-based quality improvement projects into the
format of education at a level that PLWD can understand and apply to their everyday
lives. Technology is rapidly growing, necessitating continued hands-on training of these
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variable technological gadgets to promote the optimization of the devices, therefore
providing the best outcomes. Using the basic mechanisms of these intricate devices is
wasting the depth of technology that is designed to enhance the quality of life, and it is a
failure of the medical community when PLWD use such technology in the most basic
fashion.
This doctoral project evaluated another level of education that nurses can provide
to PLWD utilizing CSII technology that promotes optimization of glycemic control,
reducing known complications associated with uncontrolled diabetes.
Transferability of Knowledge
Identifying the gap in practice with CSII technology and diabetic selfmanagement skills, future nursing projects can continue identifying specialized arenas in
health in which CSII technology can be used. Improving diabetic self-management skills
can also parlay into other chronic conditions, educating a multitude of patient populations
on self-management skills and the promotion of positive outcomes. One area of interest is
applying CSII technology and the initiation of this modality in people who suffer from
Addison’s disease. CSII technology could be used to provide continuous cortisol through
the advanced technology that CSII therapy provides. The understanding of technology,
and using it to its full potential, is critical in quality of life as well as positive outcomes.
Nursing research on patient safety is profoundly important, as is linking the appropriate
tools to the knowledge needed to be successful.
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Implications for Positive Social Change
There is limited research focusing on patient education geared toward CSII
technology and future advancements associated with this therapy. It is important for
PLWD who require CSII therapy to thoroughly understand the technological aspect of
this treatment and acquire knowledge to promote improvement in glycemic control. It is
believed that, with further education that is person-specific to diabetes and utilizing
complex functions associated with CSII therapy, there will be improved compliance and
a reduction in complications associated with uncontrolled diabetes. With the reduction in
complications of diabetes, costs associated with treatment will be positively affected,
along with quality of life, for those diagnosed with the disease.
Summary
Normalizing HgA1c levels in PLWD requiring insulin therapy promotes better
patient outcomes by decreasing morbidity and mortality rates, as well as minimizing the
impact of socioeconomic and quality of life issues. With normalized glycemic control,
PLWD will experience a reduction in the negative effects of diabetes such as
nephropathy, neuropathy, and retinopathy, along with cardiovascular problems.
Improving outcomes for PLWD with education can enhance quality of life for
PLWD and family members. As I have worked with this population, it has become
apparent that there is a gap in nursing and the promotion of education to improve selfmanagement and technological skills of those PLWD utilizing CSII therapy. Upon
evaluation of this QIP, I developed a clearer insight on the gap in nursing, education and
normalization of HgA1c levels.
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Section 2: Background and Context
Introduction
The diabetes clinic that performed the QIP estimates that over half of its patients
are diabetics, and new diabetic patients are being referred to this clinic on a daily basis. It
is estimated that about a quarter of the PLWD that are seen in this diabetic clinic utilize
CSII therapy. When oral glycemic agents fail to control blood glucose levels in T2D,
insulin therapy becomes the mainstay of treatment. For T1D, insulin is the only avenue of
treatment related to the destruction of pancreatic beta cell production (McCulloch, 2016).
With the administration of insulin, MDI therapy used to be the only avenue for PLWD to
control blood glucose levels. MDI therapy entails correct calculation of carbohydrate
intake, as well as blood glucose levels, along with the administration of insulin at specific
times throughout the day based off of these calculations. Compliance with MDI therapy
can become a significant barrier to the normalization of blood glucose levels associated
with the multiple finger sticks required daily, averaging four to six times, to obtain
accurate calculations, along with three to four daily injections of insulin daily.
In 1963, Dr. Arnold Kadish invented the first portable insulin pump; more than 10
years later, in 1976, Dean Kamen designed the first wearable insulin pump (Ghazanfar et
al., 2016); also known as CSII therapy. Over the past 40 years, CSII therapy has
advanced as researchers race to develop the artificial pancreas. These new technologies
are proving to have an impact on glycemic control in relation to reducing the number of
injections PLWD have to administer through the day with MDI therapy. CSII therapy is a
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promising advancement in treatment for diabetes, reducing the complications associated
with cardiovascular disease, neuropathy and nephropathy, and cholesterol profiles.
In the diabetic clinic where the QIP took place, a large majority of PLWD
initiating CSII therapy experienced improvement in HgA1c levels. Unfortunately, it
became evident through routine follow-up that this improvement was short-lived in many
CSII users, as evidenced by declines in HgA1c levels over time. This decline may be
associated with a knowledge deficit, poor patient compliance with the use of this
sophisticated technology, a lack of sufficient patient education focusing on CSII
technology, or the interaction between the patient and health care provider.
The objective of the evaluation of the QIP is to recognize the impact of three 45minute educational sessions on compliance and reduction in HgA1c. As the QIP has not
been evaluated, there is a gap between administration of advanced education for PLWD
using CSII therapy and the outcome of that education. Normalizing HgA1c levels in
PLWD requiring insulin therapy promotes better patient outcomes, decreases morbidity
and mortality rates, and improves socioeconomic consequences and quality of life. With
the normalization of glycemic control, PLWD will experience a reduction in negative
effects of diabetes such as nephropathy, neuropathy, and retinopathy, along with
cardiovascular problems.
In this section of the paper, the evidence-based model used to guide the QIP
project is described in further detail, along with the project’s relevance to nursing
practice, and the local background and context in which the project was developed. The
role of the DNP study is further outlined in this section.
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Frameworks, Concepts, and Models
The use of theory in advanced practice nursing is necessary to provide a
framework in directing patient care and implementation of interventions. The Integrated
Theory of Health Behavior Change (ITHBC) is a framework that works to engage the
patient in positive behavior changes to improve or manage chronic illness. Ryan (2009)
found that approximately 50% of chronic illness is caused by personal behaviors. The
promotion of health and behavior changes is critical in improved patient outcomes. The
ITHBC theory was the framework used to guide the nurse-led educational sessions for
the QIP as it fostered increased participant knowledge, understanding and selfmanagement skills when using CSII therapy (Ryan, 2009). As the ITHBC promotes
engagement in self-management behaviors, the desired outcome is positive long-term
change (Ryan, 2009). Ryan (2009) found that self-regulation, the key component of the
ITHBC, recognizes the importance of setting appropriate goals, self-monitoring, which is
a critical component to success of CSII therapy, decision making, and planning for, as
well as engaging in, specific behaviors needed to adequately and safely control a chronic
illness. The ITHBC also engages in social facilitation understanding the impact of social
influence, support and promotion of self-management skills (Ryan, 2009). All the
components of the ITHBC provided the needed guidance for a successful outcome of the
QIP.
The CDC Process Evaluation Model (PEM) is defined as a business process that
has a specific order of activities that occur across time and place (CDC, 2004). This
model is a structure that emphasizes six interlinked steps that provide the framework to
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tailor an evaluation toward a specific goal that is time oriented. The CDC PEM helps to
organize and summarize the important elements of the QIP. Each step in the evaluation
process is reliant on the completion of the previous step, creating a focal point of
completion to move forward (CDC, 2004). The CDC PEM is a representation of one or
more processes and the association of these processes performed by the research team
(CDC, 2004). Utilizing a model that describes activities across time and place helped to
distinguish and define gaps in the QIP and optimized glycemic control. Future objectives
will also be defined by the PEM, as it will recognize areas that need improvement for
successful outcomes.
Project Relevance to Nursing Practice
Nursing can provide diabetic education, especially in the early stages of T2D, as
illustrated by Robertson (2012). Robertson reports clinical studies that support the
positive effects of patient education and self-management, leading to better clinical
outcomes. Also, according to Robertson, with well-informed patients, prevention of
chronic disease will be evidenced through normalization of HgA1c levels. This, in turn,
will promote improvement in quality of life and decrease in health care costs. Education
is key in promoting better outcomes with PLWD requiring insulin therapy and those that
require CSII therapy.
Diabetes affects 25.6 million Americans over the age of 20 (Robertson, 2012).
Early diagnosis improves outcomes; however, the management and/or treatment of
diabetes is paramount in the reduction of chronic disease. Nursing is pivotal in fostering
patient/provider interaction along with introducing the necessary education and support

23
based on preventive treatment modalities along with lifestyle modifications. As nursing is
patient oriented, spending more time with patients over physicians, the opportunity for
education is more attainable. Robertson (2012) recognized the importance of behavioral
patterns affecting lifestyle choices, along with continued patient/provider interaction;
behavior and interaction are pivotal at enhancing the success of CSII therapy. Nursing
has a solid role in reinforcing lifestyle changes with each encounter with a patient,
reinforcing previous educational experiences. This doctoral project offers a better
understanding in the gap between the use of CSII therapy, education, the normalization of
glucose levels, and nursing’s role in the educational process. As indicated through the
researched literature, CSII therapy promotes improved HgA1c levels. However, with the
necessary education and nurse/patient interaction, outcomes may improve.
Literature Review
Search Strategy
To find the most appropriate evidence-based literature associated with CSII
therapy, self-care management skills, and education, multiple search sites were used.
These include Medline, Cochran, ProQuest, PubMed, Cumulative Index to Nursing,
Google Scholar and Allied Health Literature (CINAHL). All studies used included a fulltext search with peer-reviewed articles. Keywords such as diabetes, CSII, insulin pumps,
MDI, usability, HgbA1c, type 1 diabetes, type 2 diabetes, and education were used in the
search for relevant evidence-based literature. The initial search, which used keywords
diabetes and education, elicited 2,709,276 articles. With the addition of the other
important keywords, such as nursing and insulin pump therapy, articles were narrowed
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down to 861,926, with a final narrowing of the search to 25,852. Upon review of the most
relevant and up-to-date literature, 176 articles were accepted for a much more thorough
review, of which 10 articles were used for the literature review based on the criteria set
for the project.
This literature review provided an overall understanding of CSII therapy, the
technology associated with this state-of-the-art treatment, as well as diabetes education
and the positive effects of these concepts in the optimization of HgA1c and glycemic
control. This literature review also addressed the absence of research associated with
T2D and the use of CSII therapy to optimize glycemic control, along with providing an
improvement in overall quality of life for all PLWD. Health-related quality of life
(HRLQ) is an essential element in the outcome of clinical trials, as well as overall health
care (Varni et al., 2003). Diabetes Quality of Life (DQOL) measurement is the disease
specific HRLQ used to pinpoint complications and recognize control of diabetes through
educational measures, according to Varni et al. (2003). Despite new technology,
therapeutic and treatment modalities, diabetes for most PLWD continues to be suboptimally controlled. This is where additional educational approaches that focus on both
the technological aspect of CSII therapy, as well as a personalized approach to diabetes
education, can enhance treatment plans and promote improvement in glycemic control.
Nicolucci et al. (2013) found that most PLWD are not actively engaged with their
health care providers and that education, along with psychosocial guidance, is missing in
the treatment approach. In the Diabetes Attitudes, Wishes and Needs second study
(DAWN2), 8596 adults with the diagnosis of diabetes in 17 countries were enrolled
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(Nicolucci et al., 2013). Interestingly, as Nicolucci et al. (2013) found, no one country’s
outcomes were better or worse than others. Depression, using the WHO-5 Well-Being
Index [(WHO-5) score < 28] was 13.8%, diabetes-related distress [Problem Areas in
Diabetes Scale 5 (PAID-5) score > 40] was reported by 44.6% of participants, and overall
quality of life was rated either ‘poor’ or ‘very poor’ by 12.2% of participants (Nicolucci
et al., 2013).
Identifying personal barriers associated with diabetes is necessary in designing a
personalized educational program for PLWD. This DNP student theorizes that, through
the evaluation of the QIP, future nurse-led educational opportunities can be developed
based off of the evaluation principles and outcomes. With a better understanding of the
outcomes of this QIP through the evaluation, the promotion of future nurse-led
educational opportunities can enhance positive patient outcomes in a multitude of chronic
illnesses.
Education is the basis of understanding any disease process, and relieving the fear
associated with the unknown. Maia, Reis and Torres (2016) found that in a longitudinal
descriptive study providing self-care management education to 151 adults living with
T2D aged 30-85, participants gained improvement in self-management skills (P < 0.05).
Wu et al. (2013) also conducted a Quasi-experimental design study analyzing the efficacy
of improving diabetes disease management after implementing a self-management
program with people living with T2D. The study consisted of two groups, an
experimental group (n = 141) and a control group (n = 81) (Wu et al., 2013). Post test
scores were collected for body mass index (BMI) (P <0.001), waistline circumference (P
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< 0.01), HgA1c (P < 0.001) and depression/anxiety (P < 0.001) in the experimental
group versus the control group. Post-test scores were colleceted for self-efficacy (P <
0.001) for the experimental group versus control (Wu et al., 2013). Both studies
demonstrate that PLWD can effectively improve self-efficacy/management with
educational programs that highlight specific barriers associated with optimizing diabetes
control.
A significant problem associated with the use of CSII therapy is problem-solving
when technology fails. This can become a major deterrent in the optimization of glycemic
control. Fitzpatrick et al. (2013) demonstrated in a systematic review appraising sixteen
intervention randomized controlled trials and eight quasi-experimental intervention
studies, that 36% of the adult participants, along with 42% of children, displayed
significant improvement in HgA1c. A systematic review performed by Wilkinson et al.
(2014) focused on barriers/influences of self-management/self-care in adults with T1D
and T2D. Interestingly, Wilkinson et al. (2014) found that there were barriers associated
with the day-to-day management of diabetes including communication with providers
and lack of educational programs providing the appropriate skills to successfully selfmanage diabetes. The provision of patient-specific education is vital in the success of
self-managing diabetes. It is evident in the literature that ample educational tools are
either not available, or the time to deliver quality education to PLWD is lost with the
quantity of patients seen in a clinic setting daily.
Much of the literature recognized that CSII therapy is superior to MDI therapy in
reducing the amount of insulin used daily, the number of hypoglycemic episodes, and the
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improvement in quality of life for PLWD. Unfortunately, most of the literature was
geared toward T1D and the use of CSII therapy and very little was found regarding T2D.
It is evident that, sooner than later, beta-cell production is restored with the use of insulin
in the T2D population (Choi et al., 2013). Choi et al. (2013) found that, after 6 months of
CSII therapy (P <0.001), HgA1c was decreased from 8.7% at baseline to 6.3%, and
during the subsequent 24 months, median HgA1c levels were maintained between 6.3%
and 6.5%. C. Peptide levels also began to improve after 12 months of CSII therapy (Choi
et al., 2013). Ghazanfar et al. (2016) studied that the use of CSII therapy improved the
quality of life in PLWD, improved self-esteem and mood, and decreased stress and
improved. Those participants in the study who were switched from MDI therapy to CSII
therapy showed a significant decrease in insulin requirement (P <0.005) from 1.7 + 0.9 to
1.1 + 0.6. This is a substantial finding, as weight gain will ensue with the increase of
rapid insulin, especially in T2D (McCulloch, 2016.)
Deeb et al. (2015) studied the association of various key elements of CSII
technology and the functionality of insulin pump therapy and the effects on blood glucose
levels. Deeb et al. (2015) found that the frequency of blood glucose control monitoring,
and the use of the Bolus Wizard feature of CSII therapy/technology, had favorable
association with glycemic control. Upon review of the QIP, this DNP student theorizes
that, with the provision of basic and advanced CSII technological training, along with
patient-specific diabetes educational training, specifically self-management skills,
improvement in glycemic control will ensue. When CSII therapy is initiated, training
includes the insulin pump start with a diabetic educator from the desired insulin pump
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manufacturer/company, which takes a couple of hours. Dependent on the clinic setting
initiating the CSII therapy, training can include the initial start date, or can be extended
out for a couple of days. This is not sufficient in providing the skills to appropriately
apply the technology and sufficiently improve glycemic control. This was evidenced by a
number of PLWD utilizing CSII therapy that were not controlled in the current setting of
the diabetic clinic. This information then prompted the clinic to design a QIP that focused
on nurse-led education and CSII therapy. As the DNP student works as a full-time nurse
practitioner in this clinic setting, it was the desire of the student to then close the gap in
the QIP, which was the evaluation phase to identify the outcome of the QIP educational
sessions.
Reznik et al. (2014) conducted the largest study thus far for T2D utilizing CSII
therapy, with 331 adult participants. This was a randomized control trial, with 168
participants started on CSII therapy and 163 on MDI therapy (Reznik et al., 2014).
Baseline HgA1c was 9% for both groups, with the study being conducted over a sixmonth period (Reznik et al., 2014). Reznik et al. (2014) found that the CSII group
reduced HgA1c by 1.1% in comparison with a 0.4% reduction in the MDI group. This
study provided statistical data favoring CSII therapy use in the T2D population and the
reduction and optimization of HgA1c and glycemic control. Again, a meta-analysis
conducted by Weissberg-Benchell (2003), consisting of both adults and children with
T1D, found that CSII therapy improved glycemic control better than when compared to
MDI therapy. Finally, Li et al. (2016) conducted a randomized, parallel study comparing
three groups of T2D participants using CSII therapy versus MDI therapy that consisted of
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3 MDI and 4 MDI. Findings were consistent, with CSII experiencing the most
improvement in glycemic control over MDI therapy (4.26 + 1.88 days) in the CSII group
versus (6.17 + 2.36 days) MDI3 group, and (5.81 + 2.46) in the MDI4 group; CSII group
(P < 0.05) versus MDI3 and MDI groups (Li, et al., 2016). Li et al (2016) also found that
the longstanding T2D group fared better on CSII therapy versus MDI3/4 therapy (P <
0.05).
Interestingly, although these studies provided insight into the problems associated
with self-management and diabetes, along with the lack of studies in regard to T2D and
CSII therapy, there is a barrier associated with the optimization of glycemic control and
the utilization of CSII therapy in PLWD, both T1D and T2D. This is why further study is
needed to discover whether the technological advancements of CSII therapy prevent
PLWD from optimally controlling their HgA1c.
Evidence to Address the Gaps-in-Practice
Reviewing the literature, the gaps-in-practice regarding CSII therapy were mixed,
as there were positive and negative outcomes associated with the initiation and continued
use of CSII therapy. Some of the studies had a limited time exposure to the treatment,
which could identify the positive outcomes; however, few of the studies focused on the
nurse-led educational segment that is associated with this DNP project. Gaps-in-practice
with education were very similar to what the diabetic clinic is identifying with many of
the PLWD using CSII therapy. Unfortunately, the literature was focused mainly on selfmanagement education and not strictly on person-specific education, focusing on both the
promotion of self-management skills and technological training for CSII use. For these
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reasons, it is very important to promote diabetic education that encompasses not only the
promotion of self-management but is also geared toward the ever-changing technological
aspect of medicine. A summary of this project’s literature view is presented in Appendix
B.
Local Background and Context
Evidence to Justify the Problem
Advances in the monitoring and controlling of HgA1c in PLWD requiring insulin
therapy has improved with new technology, specifically CSII therapy. With review of
existing PLWD insulin pump downloads (Trend reports) at the diabetic clinic, it has
become evident that there is a gap in the use of CSII therapy and normalization of
HgA1c. Even with the convenience associated with using CSII therapy, patient
compliance, knowledge deficit, or patient/provider interaction may be barriers to
normalization of HgA1c levels.
There is variable success with the CSII therapy reported in the literature as well
(Li, et al., 2016). The initiation of CSII therapy results in a rapid HgA1c reduction, but
then it begins to increase within the first year of therapy. The objective of this DNP
project is to evaluate the impact of the QIP on knowledge deficits and HgA1c levels. It is
theorized that the elevation in HgA1c after initiation of therapy is related to the basic
education provided at the start of therapy, along with only routine quarterly follow-up
visits for insulin pump adjustments, many times made by the provider (Maia, 2016).
Upon evaluation of the QIP, we hope to identify whether there is a gap in nursing and
patient education preventing positive outcomes associated with CSII therapy.
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Institutional Context
The intended practice setting is a diabetic clinic located in large southwestern
state that sees an estimated 100 adult patients daily for a number of endocrine disorders.
Approximately 50 percent of these patients have diabetes. There is a large volume of
diabetic patients that require oral glycemic agents, as well as MDI and CSII therapy. The
DNP student’s affiliation with the practice is as a full-time practicing family nurse
practitioner working closely with diabetic patients.
Definition of Relevant Terms
Basal insulin: A continuous 24-hour delivery of insulin mimicking the function of
the pancreas (Walsh & Roberts, 2013).
Blood glucose level: Measurement of serum blood glucose levels (Walsh &
Roberts, 2013).
Carbohydrate counting: The carbohydrates in any given food (Walsh & Roberts,
2013).
Continuous subcutaneous insulin infusion (CSII): Insulin pump therapy (Conget
et al., 2016).
Correction bolus: A delivery of insulin to correct a high blood glucose levels
(Walsh & Roberts, 2013).
Diabetic neuropathy: Damage to nerves resulting from poor glycemic control
(Walsh & Roberts, 2013).
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Diabetic retinopathy: Visual problems created from damage to the small vessels
in the eyes, which can cause blindness resulting from poor glycemic control (Walsh &
Roberts, 2013).
Glycated Hemoglobin (HgA1c): Is the most widely used clinical test correlated
with diabetes; HgA1c is the estimation of blood glucose control as red blood cells are
highly permeable to glucose (McCulloch, 2016). HgA1c reflects a mean blood glucose
over a period of 8 to 12 weeks (McCulloch, 2016).
Hypoglycemia: Lower than normal blood glucose levels defined as blood glucose
levels <70 (Walsh, Roberts, 2013).
Hyperglycemia: Higher than usual blood glucose levels defined as blood glucose
levels >100 (Walsh & Roberts, 2013).
Insulin Pump: A small device that is programmed to delivery basal/bolus insulin,
replacing MDI therapy (Walsh & Roberts, 2013).
Multiple Daily Injections (MDI): Insulin delivery via multiple daily subcutaneous
injections (Conget et al., 2016).
Type 1 diabetes (T1D): Destruction of pancreatic beta cells, which then leads
complete insulin deficiency is the classic characteristic of T1DM (McCulloch, 2016).
Type 2 diabetes (T2D): Hyperglycemia, insulin deficiency and resistance are the
classic characterizations (McCulloch, 2016); the most common type of diabetes.
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Role of the DNP Student
Professional Relationship to the Project
At Walden University, the DNP student is prepared through scholastic and
clinical experiences to meet the foundational elements outlined by the American
Association of Colleges of Nursing (AACN). The Doctor of Nursing Practice Program
(DNP) at Walden University promotes the student’s understanding of what roles and
responsibilities they should possess upon graduation. Through this preparation, my final
requirement of this DNP program was to evaluate an EB-QIP project at my chosen
practice setting prior to graduation (Walden University, n.d.). This project fulfills all
criteria to formally graduate as a knowledgeable DNP and further the future of nursing
through continued EB-QIPs.
Professional Role in the Project
Currently, my professional role is working as a family nurse practitioner (FNP) in
the diabetic clinic setting that is my chosen practice setting. My role in this setting for
this project is also as the DNP student, working daily with PLWD who require both oral
antiglycemic agents, MDI, and CSII therapy. With my current position as an FNP, I am
uniquely qualified to identify the shortfalls in glycemic control with oral antiglycemic
agents, as well as MDI and CSII therapy, as I work daily with PLWD and formulate
treatment plans.
Participants in the QIP included patients at the clinic who had been initiated on
CSII therapy. All information was provided by the diabetic clinic and was not be
retrieved by the student. No patient identifiers were used in the evaluation process, as all
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data was categorized by groups i.e., male/female. Upon categorizing the data, I was able
to recognize trends in adherence to therapy, technological difficulties, and the effects of
lifestyle on diabetes.
Motivations for the Doctoral Project
Working daily with PLWD requiring CSII therapy, the DNP student recognized a
trend between the initiation and follow-up of CSII therapy, and a gap in normalizing
glycemic control. It has been the DNP student’s experience, through close observation
and working with PLWD requiring insulin therapy, that initially there is significant
improvement in HgA1c levels within a six-month period from initiation of CSII therapy;
however, this improvement is not sustained. There may be a number of factors that
preclude the sustainment or normalization of glycemic control. These include, but are not
limited to, patient tolerance and/or intolerance to insulin and therapy; biological changes
to the patient as a result of age or gender; endocrine system function; patient lifestyle and
stress levels; provider interaction and/or monitoring intervals; Sensory-Augmented Pump
Therapy (SAPT); and CSII technological shortfalls (Maia, 2016). It is the goal of this
project to identify whether this trend is the norm, or a lack of sufficient education in both
self-management skills and technological training specific to CSII therapy.
Potential Bias
The appearance of bias may be implied if the evaluator of a QIP favors a
particular outcome. This could potentially cause bias toward the outcome of the
evaluation, having it lean closer to the favored end. Another form of bias could be the
selection of the participants in the QIP. As the QIP involved nurse-led educational
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sessions, participants with high learning aptitudes could have been chosen, which could
have promoted a favored outcome as well. As the DNP student did not chose the
participants in the QIP, and will not be extracting data for the evaluation process, bias
should not be an issue. Upon initiation of the QIP, the diabetic clinicians felt it was best
to use one manufacturer for the initial training. As there are three main CSII
manufacturers that the diabetic clinic works with, using one manufacturer eliminated any
bias upon evaluation of the QIP, as each manufacturer has different reports to follow
behavior, blood glucose levels, and administration of insulin. The use of one
manufacturer allows for equal evaluation of the trend report categories.
Summary
There is variable success with CSII therapy reported in the literature. HgA1c is
the gold-standard measurement of glycemic control, and affords health care providers a
value in which to recognize a patient who may be noncompliant, complacent, or lacks the
knowledge associated with optimizing CSII technology. It has been identified that
patient-provider interaction is critical to the success of lowering HgA1c levels and
optimizing the use of CSII technology. Nursing plays a pivotal role in delivering specific
patient-centered education/training on CSII technology and self-management of diabetes,
as evidenced by the literature.
Patient behavior impacts the longevity of CSII therapy, and can be transformed
with appropriate educational approaches within the nursing context. As evidenced in the
literature thus far, optimization of CSII therapy is questionable, which can be attributed
to a number of reasons. This DNP project will evaluate the success of the QIP, which
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consisted of three 45-minute educational sessions and their impact on improvement in
HgA1c and patient compliance. It is theorized that, with the proper tools through
continued education to operate CSII technology, PLWD will become more compliant in
entering the correct data, in turn receiving the appropriate amount of insulin to optimize
glucose levels and improve HgA1c levels.
Essential for the implementation and evaluation of any intervention employed by
advanced practice nurses is to identify theories specific to the intervention and evaluation
desired. The ITHBC theory was used as the framework of the QIP, along with the CDC
PEM theory that was used in this DNP project as the framework to guide the evaluation
of the QIP. By using a theory-based approach in nursing, time wasted in evaluating
irrelevant material and the avoidance of distractions can be prevented. Also, use of a
theoretical framework can foster improvement in communication among peers, patients,
and other professionals. Using the CDC PEM and the ITHBC Theory, recognition of
possible shortfalls in the educational process can be ascertained and adjustments to the
educational program can be applied to improve health outcomes of future participants.
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Section 3: Collection and Analysis of Evidence
Introduction
Quarterly follow-up visits for PLWD using CSII therapy have been routine at the
diabetic clinic where the QIP took place. These routine visits include insulin pump
downloads and interpretation of the data retrieved from the Adherence Report, among
other reports. This interpretation helps the clinician determine any necessary changes to
help optimize glycemic control. In depth education focusing on CSII technology is
minimal at these visits for a number of reasons, most significantly time restraints. This
has resulted in many PLWD underusing the many functions of the CSII technology. The
purpose of this DNP project was to evaluate the impact the QIP had on promoting selfmanagement skills and improving the knowledge deficit and HgA1c levels.
As identified in the literature review, Bode (2010) found that the complexity of
CSII technology was a notable barrier to the compliance of PLWD, as well as
optimization of HgA1c levels. Bergenstal et al. (2013) found key contributors to poor
glycemic control among PLWD utilizing CSII therapy included the underutilization of
glucose data, as well as inconsistent glucose data collection. This is a common
occurrence in the diabetic clinic and prompted this DNP project.
This section elaborates on the study design, extraction of data, methodology and
description of how the extracted data was analyzed. Specific goals and objectives are
established in order to develop an appropriate research methodology to secure a positive
endpoint in successfully reaching the goals and objectives identified for this DNP project.
Upon completion of the evaluation of the QIP initiated at the diabetic clinic, recognition
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of possible short-falls in the educational program can be identified and corrected to
improve outcomes for future program participants.
Practice-Focused Question
Thanks to new technology, there have been significant advances in the monitoring
and controlling of HgA1c in PLWD over the last decade. Despite these advances, PLWD
requiring insulin using the most up-to-date technology, for example CSII therapy,
continue to fall short in optimizing HgA1c levels. Working closely with the diabetic
population in the diabetic clinic setting, through evaluation of data derived from the
insulin pump Adherence/Trend Reports, I discovered that there is an apparent knowledge
deficit in the correct use of the technology. This deficit, or problem, became the focus of
the DNP question: How will nurse-led educational sessions for PLWD using CSII
therapy impact the knowledge deficit and HgA1c levels? As Wu et al. (2013)
demonstrate, continued patient education can improve self-efficacy and self-management
of diabetes, promoting awareness of the importance of diligent glucose monitoring and
proper use of advanced technology. Without the tools to be successful in these advanced
technologies, many PLWD will be at a loss in managing the intricate applications of
CSII.
Project Purpose and Method Alignment
The purpose of the DNP project was to evaluate the QIP that was implemented at
the diabetic clinic that consisted of three 45-minute educational session for PLWD using
CSII therapy. The data retrieved for the evaluation process was provided to me from the
clinic for evaluation purposes, allowing me to recognize trends in adherence to therapy,

39
technological difficulties, and the effects of lifestyle and diabetes. No patient identifiers
were used in the evaluation process, as all data was placed in categories appropriate for
the evaluation. Also, through the evaluation, the data retrieved via the Trend reports
distinguished whether or not there was improvement in compliance, understanding and
usability of CSII therapy. This information is relevant, as attitudes of PLWD play a
significant role in compliance and optimized HgA1c levels. Evaluation of all data,
combined through Trend reports and aggregate serum laboratory HgA1c levels 3 months
pre-education and 3 months post-education, served as a means of quantifying the end
goal of this QIP: improved compliance and HgA1c levels.
Key Operational Definitions
Adherence Report: Reports patient behavior data for a specific period of time
(normally 2 weeks). This report provides adherence through data such as glucose
measurements, bolus events, and insulin pump activities (Medtronic, 2009).
Log Book Report: Presents glucose, carbohydrate levels, and insulin infused on
hourly intervals (24 hours). This report recognizes glycemic control over a specific
period of time (2 weeks) (Medtronic, 2009).
Device Settings Report: This report lists all insulin pump settings. This
information is used as a guide in the interpretation of other reports and to make
appropriate adjustments to insulin distribution based off of information obtained through
the other trend reports (Medtronic, 2009).
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Trend Reports: A few reports that include all function of CSII technology
focusing on usage by the user. These reports are used to properly monitor and adjust
treatment (Medtronic, 2009).
Statistics Table: Provides measurements including average blood glucose, number
of meter glucose reading, readings above and below target settings, carbohydrate daily
average, bolus daily average, basal daily average, and average total daily insulin
(Medtronic, 2009).
Sources of Evidence
Archival and Operational Data
The clinic used two sources of data, current and archived. Data used for this
evaluation came from the electronic medical record (EMR), as well as the CSII database.
All information was provided to me by the diabetic clinic for evaluation purposes. No
patient identifiers were used in the evaluation process.
Description of Data Collection
The diabetic clinic provided all data necessary for the evaluation void of patient
identifiers. Data consisted of information provided from each participant’s Medtronic
insulin pump Trend Reports, specifically the Adherence Report. The extraction of
Adherence Reports occurred at each visit at the diabetic clinic and was recorded in the
patient’s electronic record. The Adherence Report focuses on behavioral data that is
based off of daily indices such as glucose measurements, bolus events, and other insulin
pump activities (Medtronic, 2009). Aggregate serum HgA1c levels were provided to me
from the diabetic clinic at 3 months pre-education and 3 months post-education and,
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again, no patient identifiers were present as each data set was placed into categories for
evaluation.
Participants
This EB-QIP took place at the diabetic clinic where I work as a full-time FNP,
and am completing my clinical experience as a student. The participants of the EB-QIP
were male and female patients at the diabetic clinic who volunteered to participate, were
> 18 years of age, with T1D and T2D using a CSII device (Medtronic) for glycemic
control with a HgA1c > 8.
Procedure
Walden University requires that an Institutional Review Board (IRB) application
be completed by all DNP students for EB-QIP projects that include the collection and
analysis of data concerning people, projects that are addressing gaps in practice, and all
doctoral projects (Walden University, n.d.). The IRB approval ensures proper conduct
from the DNP student in performing the EB-QIP, along with the evaluation of the EBQIP devoid of any coercions to the participants of the EB-QIP (Walden University, n.d.).
As stated earlier, all data was retrieved from the diabetic clinic, void of patient
identifiers, and provided to me for evaluation of the QIP. This commenced only once IRB
had been approved. With the use of the categorical data, along with aggregate serum
HgA1c levels pre-and post-educational sessions that were also categorized between male
and female participants, trends were identified indicating success or need for educational
session improvement.
Protections
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Pump reliability and validity was based on approval through the Federal Food,
Drug, and Cosmetic Act (FDA). This Act includes annual registration, listing of devices,
good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Safety assurance cases are provided to the FDA for pump devices, which
demonstrate acceptability of risk mitigations, adequate device reliability, and adequate
designs verification and validation of device specifications (HHS, 2015). Patient
reliability was not guaranteed as necessary data to create sufficient information for pump
download needed to be uploaded into the device by the patient.
Analysis and Synthesis
Data Systems and Procedures
Microsoft Excel was used to organize data, data sets, and variables. Maintaining
control of the data collection, specific criteria must have been met prior to entering a
participants’ information into the project; as I was not retrieving the information, and was
provided it from the diabetic clinic performing the QIP, all data was required to be void
of any patient identifiers. Also, all data was placed in categories specific to the evaluation
process. This information was vital to the findings and outcomes of the project.
Data Integrity
If there was any data missing from the CSII downloads, it was first determined if
this information had a significant impact on the analysis. As Grove et al. (2013) explain,
it may have to be excluded from the project depending on the impact of the information.
During the evaluation of the EB-QIP, outliers may have been identified. According to
Polit (2010) outliers are numerical values that are outside the normal range of the values
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for the other data. An example of an outlier for this project would include those
participants with glycemic control that appeared to be optimized by a serum HgA1c level
well below 6.0. However, false appearing-optimized HgA1c could have been in relation
to blood glucose variability, which can cause untoward effects on internal organs.
Significant variability in blood glucose levels can be as hazardous to the
promotion of complications from diabetes as uncontrolled hyperglycemia is (Service,
2013). This variability is also a sign of knowledge deficit in the understanding/usability
of CSII technology. To ascertain the accuracy of an outlier, the data needed to be
scrutinized to identify where the error occurred. Errors could have occured while data
was entered either by using improper values or codes as Polit (2010) explains. Also, Polit
(2010) reports that outliers can be found through data cleaning; inspecting values through
the frequency distribution.
Data Analysis
A simple t-test was used to compare two averages and identify differences, and as
to whether those differences happened by chance. Also, a run chart was used to review
the trends for each CSII download look at the progression of specific data points over
time. The run chart was important, as non-statistically significant trends can be identified
with multiple data points over time.
Descriptive statistics were used to summarize the sample characteristics and from
this description a frequency variable was plotted based off specific variables such as
HgA1c levels, number of times patients checked their blood glucose levels daily, number
of times the tubing/setting was changed, and number of times BWZ and the override
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function were used. IBM SPSS software was used for the statistical analysis of this
project.
Summary
Medications and technology have had a profound effect on diabetes; however,
with even the newest advances in technology, normalization of HgA1c with the use of
CSII therapy still has its downfalls. Through evaluation of quantitative data retrieved
from serum laboratory studies and data from the Trend Reports acquired from the CSII
database, recognition of the gap in achieving improved glycemic control, as well as selfmanagement skills for those PLWD utilizing CSII therapy can be achieved.
With the implementation of the three 45-minute educational sessions, and the
existing data gathered pre- and post-session, the evaluation of the EB-QIP identified gaps
in education, the use of CSII therapy, and the optimization of glycemic control. The
population size was determined based on the criteria established by the diabetic clinic
performing the QIP. All ethical principles were followed closely during the evaluation of
the QIP in order to protect participant information. No personal information was used or
divulged in the study.
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Section 4: Findings and Recommendations
Introduction
Regardless of being given the most up-to-date treatment for T1 and T2D, using
the most advanced technology in the form of CSII therapy, PLWD continue to struggle
with controlling blood glucose levels. Complications associated with uncontrolled
diabetes include, but are not limited to, cardiovascular/cerebrovascular disease, renal
impairment, vision problems such as retinopathy, and peripheral neuropathy that can lead
to amputations (McCulloch, 2016). McCulloch (2016) estimates that 14% of health care
expenditures in the United States, or $245 billion, is used to treat the complications
associated with uncontrolled diabetes.
Type 2 diabetes is on a swing upward in growth, with expectations of an increase
to approximately 64% according to Rowley and Bezold (2012). This is an increase from
19.1 to 53.1 million by the year 2025 (Rowley & Bezold, 2012). That new treatment
modalities such as oral glycemic agents, improved insulin dialogs, and updated
technology do not appear to be controlling the issue at hand is concerning. T2D is
expected to increase to approximately 415 million cases worldwide (Rowley & Bezold,
2012); equating to an annual economic impact of $500 billion.
Through my observation of PLWD utilizing CSII therapy in the clinic setting, it
had become obvious that there was a gap between the initiation of CSII therapy in PLWD
and continued education. This gap may contribute to the lack in achievement of optimal
glycemic control. Through evaluation of insulin pump reports it was also apparent that
that many CSII users were making use of only minimal features of the CSII technology.
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As a result, the development of a quality improvement project was initiated to determine
whether a nurse-led educational program would enhance the usability of the CSII
technology, thus improving HgA1c levels and outcomes by reducing complications
associated with T2D. The primary concentration of the practice-focused question was
whether a nurse-led educational program could promote self-management skills, improve
the knowledge deficit with regard to the usability of CSII technology in PLWD, and
improve HgA1c levels. With the practice-focused question aligned, three 45-minute
nurse-led educational sessions were performed specific to each participant. The purpose
of this doctoral project was to evaluate the outcome of the educational sessions and to
determine whether there was a positive impact on the participants’ HgA1c levels posteducation.
I obtained evidence for this project through the insulin pump reports downloaded
with each session, using the Adherence Report, and the serum aggregate HgA1c levels of
each participant three months pre-education and post-education. The Adherence Report
provides information about the participant’s compliance with the use of CSII technology,
allowing for daily, weekly and monthly views of usability. Serum aggregate HgA1c
levels are important in gauging improvement in participants’ glycemic control.
Subsequently, I categorized and assessed the information obtained to determine
participants’ improvement in CSII features. I assessed serum aggregate HgA1c levels to
recognize improvement and/or failure to improve from the initiation of the program. Prior
to the implementation of the project, I obtained an approval from the internal medicine
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clinic’s director, as well as Walden Universities Institutional Review Board (IRB); IRB
approval number is 01-30-18-0410353 .
Findings and Implications
Demographics and Descriptive Data
Over a period of six months, a total of 122 patients were identified as potential
participants at the diabetic clinic where the QIP was performed. Out of the 122 patients,
34 signed up to participate in the QIP, a nurse-led educational program that consisted of a
series of three 45-minute educational sessions that were patient-specific. One nurse
practitioner at the site performed the educational sessions and reviewed the Adherence
Reports, most specifically the Trend Reports and serum aggregate HgA1c levels. This
information created the guiding principles of the QIP.
Out of the 34 participants, one expired, three were lost to follow-up, and four
withdrew from the program due to time restraints. PLWD (T1D and T2D) who utilized
CSII therapy for the administration of insulin for one year or greater were included in the
QIP. Other parameters for inclusion in the program were participants having a HgA1c > 7
or significant variability in daily blood glucose levels that can falsely lower HgA1c levels
within optimum range. As Hirsch (2015) found, using the HgA1c to correlate diabetes
control is leaving many people, especially those with T2D, with uncontrolled diabetes in
relation to glycemic variability (GV), thus creating opportunity for continued
complications associated with diabetes. According to Hirsch (2015), GV should be
considered as a first-line indicator of optimal diabetes control.
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Upon evaluation of the QIP, patient safety and privacy were of the utmost
importance. There was no identifying participant information provided to me for
evaluation purposes. All data collected was provided to me by the site that the QIP was
performed. I placed the data in categories using Microsoft Excel. My analysis of the
categorical information commenced upon IRB approval.
Descriptive Data
The results of the evaluation involved secondary data consisting of Trend Reports
from the insulin pumps, void of any participant identifying information, along with
aggregate HgA1c levels provided by the site where the QIP took place. I placed all data
into categories specific to the evaluation to provide a comparison from the initiation of
education to completion of the educational program. The QIP consisted of 26
participants; n=12 (46%) were male, and n=14 (54%) were female. Average age of the
male group was 69.8 years; average age of the female group was 54.2 years, with an
overall combined average age of 61.5 years.
No oral glycemic agents or additional diabetic medications were added or
removed from the participants’ regimen during the QIP, negating any additional
adjustments to HgA1c levels r/t new medications or changes to current treatment
regimen. This was done to avoid changing any of the end results that would alter the
outcome of the educational program. All participants used one CSII manufacturer,
eliminating any differences in technology, use, or performance. Aggregate serum HgA1c
levels of each participant were provided to me for evaluation purposes, again, void of any
participant identifying information.
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Results
I performed all statistical analyses using IBM SPSS version 24, with all
categorical information input into Microsoft Excel. I met the goal of determining the
effect of the nurse-led educational sessions over time by performing a one-tailed, paired
samples t-test with the level of significance set at .05. I identified four categories
allowing for the necessary statistical evaluation: serum aggregate HgA1c levels, blood
glucose log use, Bolus Wizard use, and override use.
Table 1 illustrates the comparison of the pre-education and post-education
categories. Table 2 illustrates each category’s data.
Table 1
Comparison of Pre-Education and Post-Education Categories
Variable

Mean

Standard Deviation

Pre-Education HgA1c

8.98

1.68

Post-Education HgA1c

7.99

1.16

Pre-Education Bolus Wizard

3.67

2.26

Post-Education Bolus Wizard

3.86

2.17

Pre-Education Blood Glucose

3.49

1.20

Post-Education Blood Glucose

4.02

1.83

14.26

24.68

10.35

21.35

Pre-Education Override

Post-Education Override

P Value

.001

.246

.081

.17
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Table 2
Trend Report Data Participants (n=26)
Category

Session 1

Session 2

Session 3

Average use Blood
Glucose log
Male/Female (n=26)

3.5

3.6

4.0

Males (n=12)

3.9

3.9

4.3

Females (n=14)

3.1

3.2

3.8

Average Bolus Wizard
Use
Male/Female (n=26)

3.6

3.8

3.8

Males (n=12)

3.5

3.8

3.8

Females (n=14)

3.8

3.7

3.9

Average Override %
Male/Female (n=26)

14.3

14.2

10.3

Males (n=12)

13.0

12.7

12.4

Females (n=14)

15.3

15.4

8.5

The above tables represent the four categories pre-education and post-education.
The pre-education mean of serum aggregate HgA1c levels was M = 8.98 (SD = 1.68). By
comparison, the mean of post-education serum aggregate HgA1c levels decreased to M =
7.99 (SD = 1.66), t(25) = 3.8, p< .05.
The mean of blood glucose log use, category two, was M = 3.49 (SD = 1.20) preeducation. By comparison, post-education was associated with a numerically greater
blood glucose log use, M = 4.02 (SD = 1.83), t(25) = -1.4, p> .05.
The mean of Bolus Wizard use, category three, was M = 3.67 (SD = 2.26) preeducation. By comparison, post-education was associated with a numerically larger Bolus
Wizard use, M = 3.86 (SD = 2.17), t(25) = -70, p> .05.
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The mean of override use, category four, was M = 14.26 (SD = 24.68) preeducation. By comparison, post-education was associated with a numerically smaller use
of the override function, M = 10.35 (SD = 21.35), t(25) = 2.4, p < .05.

Figure 1. Blood Glucose Log

Figure 2. Serum Aggregate HgA1c Pre/Post QIP
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Figure 3. Average use of Bolus Wizard

Figure 4. Average Use of Override
The above figures demonstrate the comparison between pre-education and posteducation in the use of the blood glucose function, serum aggregate HgA1c levels, Bolus
Wizard, and the use of the override function.
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Unanticipated Limitations/Outcomes and Their Potential Impact on Findings
This project had a number of unanticipated limitations. First, the number of
participants could have been larger to provide more data sets. With the small number of
participants in the QIP, statistical significance in the analysis of the evaluation may have
been lower than anticipated. Secondly, the turnover in medical assistant staffing within
the diabetic clinic, and the need to train new staff, created issues with lost data from the
insulin pump downloads, decreasing the potential for larger numbers of participants in
the program. Vital information that is routinely extracted from each CSII device is to be
scanned in each patient’s chart at each visit. With new staff, routine processes within the
clinic were neglected and vital information was lost.
As insulin pumps are the newest technology in diabetes management,
technological failures were also problems associated with the analysis of the programs’
success. There were a few participants who experienced technological difficulties with
the insulin pumps requiring assistance from the manufacturer. In relation to lost data, two
of the participants’ follow-up sessions had to be rescheduled to allow for appropriate data
collection prior to the upcoming session. Expanding the hours of operation may have
alleviated time-restraint issues that necessitated some participants withdraw from the
program.
Implications for Individuals, Communities, Institutions, and Systems
The implications of this study shed light on the importance of continued nurse-led
education. Although the number of participants in the QIP was small, the results
indicated improvement in all four categories with respect to number of times the
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participants checked their blood glucose levels daily, the number of times the participants
used the Bolus Wizard feature, and the reduction in the percentage of overrides
performed by the participants. This information is critical in promoting improvement in
blood glucose levels. The most telling statistic from the analysis of the data was the
reduction in the overall HgA1c by an average of 1.1 post-education. This reduction in
HgA1c is significant as indicated in the UKPDS study that demonstrated tight control of
HgA1c levels proved decrease microvascular complications (King, Peacock & Donnelly,
1999).
The results of this project have provided keen insight as to the importance of
continued diabetic education in the prevention of the complications associated with
uncontrolled diabetes at this clinic. As the future of diabetes treatment continues to
rapidly change, it is crucial that providers, as well as patients, continue to be educated on
the state-of-the-art technological changes used for the treatment of diabetes.
The diabetic clinic where the QIP and evaluation was performed is a very busy
clinic, with approximately 50% of the patient population treated for diabetes. The average
time allotted for patient visits is 15 or 30 minutes. This does not leave a great deal of time
for patient education. However, upon my review of the results from the evaluation of the
QIP, it has become apparent that with specific time set aside for more thorough
education, improvement in HgA1c levels can be achieved. Though the diabetic clinic is
independent, having no association with a hospital system or additional clinics, the
findings can still be shared amongst nursing peers, prompting similar clinics to institute
nurse-led education focusing on diabetes and the use of advanced technologies.
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Legal, Ethical and Economic Implications
Beneficence, the act of preventing harm, is critical in the treatment of diabetes or
any other chronic disease state. With the provision of educational sessions for PLWD
utilizing CSII therapy, a better understanding of the importance of using this technology
appropriately to arrive at the best end result is achieved. With the adoption of nurse-led
educational sessions that focus on the use of the advanced technology associated with
CSII therapy, along with continued promotion of self-management skills, complications
associated with uncontrolled diabetes can be prevented.
Diabetes has become a worldwide epidemic leading to chronic health conditions
and crippling the financial welfare of the United States and many other countries through
the world (McCulloch & Robertson, 2016). Screening for diabetes should be performed
on all adult patients in order to identify the signs of prediabetes and provide adequate
preventive treatment to reduce the complications associated with diabetes. PLWD who
utilize CSII therapy need appropriate education focusing on the use of this advanced
technology to optimally control HgA1c levels (Ghazanfar et al., 2016). This is an ethical
dilemma in the medical community, as we are neglecting the ethical principal of ‘justice’
if we do not provide this life-saving education.
It is the responsibility of the entire medical community to continue developing
quality improvement projects to redesign and establish protocols and provide the best
evidence-based practice principles (Fitzpatrick et al., 2013). Legally, it is our
responsibility to continue to update and improve old standards of operation and
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implement, through research, new standards of care to promote the best possible
outcomes.
Implications for Positive Social Change
There are social implications associated with this project in a number of areas:
PLWD, family members, the diabetic clinic, and the nursing profession. The results of
this QIP have changed the process in which PLWD utilizing CSII therapy are educated in
the diabetic clinic. PLWD who use CSII therapy will be provided additional time for
short educational sessions with each office visit. The director of the diabetic clinic
supported the QIP and has worked closely with the nurse practitioners in this clinic to
establish new policies and protocols for patient education.
Recommendations
The evaluation of the nurse-led education QIP program implemented in the
diabetes clinic addressed gaps in knowledge deficits experienced by PLWD using CSII
therapy for the treatment of diabetes. Formulating educational sessions that were
participant-specific, and focusing on CSII technology and self-management skills,
allowed a self-paced learning experience. The four categories that were the focus of the
evaluation all demonstrated improvements post-education. At the start of the QIP, the
average HgA1c level for the participant group was 8.98%; three months after completion
of the QIP, the average HgA1c level for the participant group decreased to 7.99%.
The number of times blood glucose levels are checked throughout the day can
positively influence a reduction in HgA1c over time. Looking at the blood glucose log,
the average number of times the participants of the QIP checked their blood glucose
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levels prior to the initiation of the QIP was 3.5 times daily. Three months postcompletion of the QIP, the average number of times the participants checked their blood
glucose levels increased to 4.0 times daily.
The Bolus Wizard function of the insulin pump takes into account the number of
carbohydrates that are entered into the database of the CSII technology, along with blood
glucose levels (Medtronic, 2009). The input of this information allows the technology to
formulate an adjusted insulin administration dose based off of the data entered by the
user. Prior to the initiation of the QIP, the combined average use of the BW by QIP
participants was 3.6 times daily. Three months post-QIP, the combined average use of the
BW by participants increased to 3.8 times daily.
The override function of the insulin pump allows for the user to change the insulin
administration that the BW has suggested from the formulation of the carbohydrate and
blood glucose levels the user inputs into the database. Overriding the suggestions made
by BW may indicate a knowledge deficit by the user or the misunderstanding of how to
properly use the CSII technology (Medtronic, 2009). Prior to the initiation of the QIP, the
combined average use of the OR function was 14%. Three months post-QIP the
combined participant average use of the OR function decreased to 10.3%.
Although the sample size was small, with only 26 participants in the QIP, and
statistically two of the categories failed to significantly improve, the evaluation did
provide proof that nurse-led education can improve patient outcomes. I recommend
further study with a larger population of participants to delve deeper into the positive
effects nurse-led education has on PLWD, as well as a number of other chronic illnesses.
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Second, I recommended that each PLWD who is initiated on CSII therapy be
provided education on the advanced technology of this treatment modality. This
education can be provided in individual or group settings and should consist of multiple
sessions. Upon conclusion, participants should able to demonstrate back to the instructor
what was learned. By providing intensive nurse-led educational sessions, knowledge gaps
PLWD may have regarding the advanced technology can be identified and closed, and
overall outcomes can improve.
Strengths and Limitations of the Project
Strengths associated with this DNP project include the positive outcomes noted
through the evaluation process. Although the data for two of the categories was not
statistically significant, review of the Trend Report did show improvement in all three
categories evaluated, along with a 1.0% average drop in HgA1c of the participants. This
information allowed the diabetic clinic to improve guidelines and begin to develop new
protocols that will be followed at the initiation of CSII therapy and beyond. Of course,
further study with a larger sample population is needed to delve into the positive effects
nurse-led education can have on patient populations with chronic illness.
Limitations associated with this DNP project are the small sample size of
participants and length of the QIP. When a sample size is small, it is more difficult to
discern whether improvement is due to random chance or if the improvement is related to
the intervention implemented (Grove, Burns, & Gray, 2013). Also, as this diabetic clinic
works with only an adult population, the QIP was only provided to people older than 18
years of age. Children, who make up a large portion of PLWD, were not evaluated.
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Summary
Although the evaluation of the QIP had variable success statistically, all four
categories that were evaluated demonstrated improvement post-education. The most
impressive improvement was in the HgA1c levels with a reduction of 1.1. This reduction
is significant as demonstrated by UKPDS study. Formulation of continued nurse-led
patient education programs is critical to the success in the management and use of the
advanced CSII technology and positive patient outcomes. Further study on this subject is
warranted allowing for closure in knowledge deficits and clearer understanding for both
the user and provider of these advanced technologies.
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Section 5: Dissemination Plan
Disseminating evidence into practice involves a planned process that focuses on a
target population and transfers knowledge from research into practice (Wilson, Petticrew,
Calnan, & Nazareth, 2010). According to Marin-Gonzalez et al. (2017), dissemination is
essential for communicating and implementing research findings, drawing focused
attention to stakeholders involved in the study, and clearly displaying the research
outputs. The purpose of evidence-based research is to strengthen baseline knowledge
with improved guidelines and protocols through dissemination of evidence. This crucial
element in research is the backbone of modern medicine and improved patient outcomes.
The AACN put forth the Essentials for Doctoral Education for Advanced Nursing
Practice to transform and change education required for advanced practice nursing
(AACN, 2006). This education is focused on the translation of evidence into practice
promoting best outcomes through the expansion of scientific knowledge (AACN, 2006).
The findings from this project will be used to better understand the behavior of
the patients in the diabetic clinic that use CSII therapy. As this treatment modality
continues to have technological advances, it is pertinent that patient education be at the
forefront from initiation through continuation of this therapy. I discussed the findings of
this project in detail with the director of the clinic, as well as the nurse practitioners and
medical staff. Although the EB-QIP consisted of a small population of patients in this
clinic setting, it provided great insight into the behavioral mechanisms between
compliance and complacency.
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The dissemination of the project’s findings will be ongoing in the diabetes clinic.
Discussions with educators from Medtronic have also commenced about designing new
protocols for PLWD who are being considered candidates for CSII therapy. From the
dissemination of the information obtained through the evaluation of the QIP, a few
different protocol designs are being drafted to be presented to the director of the clinic for
review. It is believed that when one of the providers in the clinic identifies a PLWD who
is a candidate for CSII therapy, the candidate should be educated on the pathophysiology
of diabetes, carbohydrates, dietary intake, and treatment options. It has been discussed
that education sessions should be broken into multiple sessions, so as not to overwhelm
the participants, and to provide a broad overview of diabetes and describe the
commitment that is required from both the PLWD and the provider.
Analysis of Self
Analysis as Practitioner
This section is interesting, as it makes me look within and describe how I view
myself. It is similar to looking in a mirror and examining the image that looks back at
you; often criticizing shortfalls. The past 14 years have been a journey; one that I knew
would end, but that end was so far in the distance I could barely see it.
My role as a practitioner is, and continues to be challenging, exciting, exhausting,
frustrating, and rewarding. This position comes with many feelings that can become
muddled. My daughter is completing her degree in psychology and one day was telling
me about the “imposter” syndrome. This syndrome can be described as a person’s
inability to outwardly show their accomplishments, always in fear of being exposed as a
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fraud (Sakulku & Alexander, 2011). There are many times that I have felt this ‘imposter’
syndrome. I am forever educating myself, but most often I feel that there is still so much
to learn so I can be up-to-date on the best practice principles to provide the best care
possible to my patients. I also have become very humbled in this field of medicine, as I
have come to realize that I am the only resource for some of my patients. As such, I have
reached the understanding that I must always continually grow and learn in my position
as a practitioner.
Analysis as Scholar
My development as a scholar has been an interesting journey. I have learned so
much through the development of this project. My understanding about research is much
greater after having had the opportunity to develop a project from the ground up and see
the difficulties and challenges that are faced. I did not go into nursing to be a researcher,
but have slowly realized through this educational process that we are all scholars. It is so
very important that I keep striving to learn the best possible ways to deliver care, and this
can only be done through research and the development, by way of evaluation and
dissemination, of best evidence-based practice principles. I definitely see myself growing
as a scholar and delving deeper into nursing research. It is through the DNP role that the
stage is set to apply research findings into the practice setting. Through the translation of
evidence-based research, protocols can be changed and improved upon. Often the
research is published, however, it is not always applied in the correct setting where it
would be of greatest benefit. My future interests will involve diabetes care and nurse-led
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education, developing new protocols for educating PLWD to improve the outcomes of
complications related to the disease.
Analysis as Project Manager
As project manager, there were many challenges I faced. The main challenge was
getting the appropriate help from the staff. This included the extraction of the deidentified data that I needed. As this is a very active diabetic clinic most days, the staff is
extremely busy. Finding the time to help get me the necessary information was difficult. I
did find that I would mostly rely on one or two specific staff members to help with me
with this part of the project.
My ownership in the project did grow with the role of the project manager,
leading to a stronger leadership role within the organization. I found that I had become
very detailed in the tasks at hand and found myself directing the staff through daily goals.
It is very important as a leader to respect your staff and have them respect you. I found
that, even through the most stressful moments, I was stronger in leading, providing
positive reinforcement, and encouraging the staff to become part of the project. This
provided great initiative, and I found that many of the staff members who appeared
disconnected to my needs as project lead started asking how they could help.
Challenges, Solutions, and Insights
Becoming a nurse was a goal of mine for as long as I can remember, and with this
goal came many challenges. Now that I am crossing the finish line of my education,
having gone as far as I can scholastically in nursing, I reflect on the many challenges I
have faced, most recently through the completion of this DNP project. The first challenge
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I encountered was really understanding what the DNP project was. It took me a very long
time to understand ‘what’ my goals and objectives were, as I felt that there were many
loose ends that needed to be tied up. However, I was unsure how to ‘tie’ them together. It
was only through hours of reading and rereading my proposal that the solution to this
challenge appeared. The solution to many challenges in life is reaching out for necessary
guidance. As such, I am grateful to my peers and instructors who helped me understand
the path of my project.
Over the past three years, I have grown immensely, finding ways to overcome
significant stress and anxiety when faced with situations that were difficult to understand.
I have reexamined my potential as a scholar over and over again throughout the past year,
questioning my ability to truly get to the end of this project. These struggles have made
me stronger, knowing that as long as I set your sights on what is most important, I can
accomplish whatever I set my mind to.
In many ways, I look at the completion of my doctoral studies and my DNP
project as finishing a marathon. I have had the pleasure of running two full marathons in
my life. The start of the marathon is exhilarating; wondering if you can accomplish such
a feat. The moment you cross the finish line, worn down emotionally and physically, the
emotions that you feel are indescribable. You are overcome with a feeling of great
accomplishment, both physically and mentally, along with the feeling of overwhelming
joy and gratitude that your body and mind carried you through. This is the same
indescribable feeling I have about completing this DNP project and completing my
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doctoral studies. It has been a marathon to complete these past three years, and my
feeling of accomplishment cannot be described in words.
The success of this project, however, was only achieved with the help of many
others. I learned very quickly that attempting anything alone is never as fulfilling as
having others work with you. Without the guidance of my committee chair and members,
my project would not be where it is today. My committee chair has been my advocate
and educator, teaching me the important steps in becoming a true scholar. Without her
and every person involved in this project, I would not be where I am today. The main
lesson learned has been understanding the importance of each person involved and
knowing when to ask questions.
Summary
Diabetes continues to be a growing problem in the United States and worldwide,
affecting 415 million people. It is the sixth leading cause of disability (Chatterjee, Khunti,
& Davies, 2017). The global economic burden, according to Chatterjee, Khunti, &
Davies (2017), is estimated at $825 billion. There are numerous treatment options
available for PLWD including oral glycemic agents, MDI therapy, and CSII therapy. The
technological aspects of CSII therapy are advancing so rapidly, providing the most stateof-the-art options for the treatment of diabetes, that PLWD and providers are left
scrambling to keep up.
Literature suggests that CSII therapy is superior to MDI therapy in reducing the
amount of daily insulin use, hypoglycemic episodes, and improving quality of life for
PLWD. The literature, however, did not provide substantial evidence about advanced
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technological education provided to PLWD and the use of CSII therapy. Deeb et al.
(2015) did, however, find that frequent use of the Bolus Wizard and blood glucose log
features of the insulin pump did have a favorable effect associated with glycemic control.
Much of the literature suggested that nurse-led education focusing on self-management
skills demonstrated an improvement in self-efficacy/management for PLWD.
The purpose of this DNP project was to evaluate the impact of a nurse-led
educational program on glycemic control. This program was designed to identify whether
or not the provision of advanced technological training for CSII therapy provided
improvement in the understanding of the CSII technology for PLWD. It was the premise
of the QIP project to improve technological understanding, thereby improving HgA1c
levels of the participants post-education.
Upon evaluation of the statistical data, it was evident that all four categories that
were evaluated improved. Although this QIP project had a small number of participants
(N=26), it did show that, with additional education, there was improvement in the
usability of the CSII technology. Through these observations, the diabetic clinic is
working closely with the representatives from the insulin pump manufacturers that are
used most frequently in the clinic to develop an educational protocol for the initiation of
CSII therapy, along with continued nurse-led education for PLWD.
It is, however, recommended that this specialized arena of nurse-led diabetes
education be further studied with a larger population of PLWD. With the advancements
in technology, it is a failure of the medical community if providers, and users of these
advance technological modalities to treat chronic illness, are not thoroughly trained on
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the functionality of the technology. To continue to develop advanced treatment options
for PLWD and not offer appropriate education on the operation of the equipment,
effective glycemic control will be lost in confusion and the treatment will continue to be
misunderstood.
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Appendix A: Summary of Educational Sessions

Self-Management/CSII (Insulin Pump) Patient Education

•

Introduction to the program.

•

Download Insulin Pump

•

Review most recent serum lab values with participant (HgA1c, C.

Session 1/Day 1 Introduction

Peptide, Fasting insulin/blood glucose)
•

Review categories of Trend Reports (Adherence report, Logbook
report, Device settings report, Daily detail report)

•

Review Adherence report with participant.

•

Correlate serum lab values with data entries in Trend reports.

•

Review previous session’s discussion and answer questions.

•

Review insulin pump download and Trend report categories ~
Review Logbook report in detail.

•
Session 2/Day 2

Discuss self-management skills to improve compliance with
Logbook entries i.e., carbohydrates/blood glucose levels.

•

Discuss carbohydrate in greater detail.

•

Discuss physical activity and nutrition and their effect on blood
glucose levels.

•

Answer questions/concerns from the participant
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•

Download Insulin Pump ~ review most recent lab values with
participant.

•

Review categories of Trend Reports ~ focus on reports from the
download that participant has questions on.

Session 3/Day 3
•

Review self-management skills that the participant is struggling with.

•

Provide educational reference material that was discussed at previous
sessions with the participant at the end of the session.
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Report

Primary
This study provides insight
into the promotion of
improved B-cell function in
T2DM with the utilization of
CSII therapy and
improvement of glycemic
control. With a reduction of
HbA1c levels from baseline of
8.7% to 6.3%, it was found
that the C. Peptide levels also
improved within a 12-month
period.

Grade

Level IV; No
groups to
compare

RCT

Secondary
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T1DM, CSII

This study provides
significant information
regarding the use of key
features of CSII technology
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This study was
comparing the
difference
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therapy and the
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glycemic
control. The
OpT2mise
study was
designed to
define the
specific role
CSII therapy
had on T2DM
and to define
safety, rate of
hypoglycemia,
patient
adherence, and
patient

the Bolus
Wizard had
favorable
association
with glycemic
control, which
was more
significant in
the children’s
groups. More
significant,
however, those
patients who
used the bolus
feature of the
CSII
technology
had better
glycemic
control.

with a
median age
of 27.5.

495 patients
were entered
into the run-in
phase of the
study, with
331
participants
randomized.
168
participants
were started
on CSII
therapy,
whereas 163
were
continued on
MDI therapy.
Baseline
HbA1c was
9% for both
groups. The
study was

T2DM
patients
with poor
glycemic
control
despite MDI
therapy, age
30-75, male
and female
~ Exclusion
pregnancy
or a
maximum
daily dose
of insulin
220 units.

therapy, insulin
pump, bolus,
glycemic control

and the improvement in
glycemic control. It also
identifies that human behavior
has a significant role in the
use of CSII therapy and
glycemic control outcome.

Grade
Level II;
Well-designed
RCT

RCT

Grade
Level II;
Well-designed
RCT

Primary
This study provided
significant statistical data
proving that optimization of
glycemic control can be
obtained through the use of
CSII therapy safely in T2DM
patients, with a reduction in
TDD of insulin.
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satisfaction.

conducted
over a 6month period
after which the
CSII group
had a
reduction in
HbA1c of
1.1% in
comparison to
the MDI group
which had a
reduction of
0.4%; the
mean
difference
between the
two groups
was 07%. The
CSII group
used a mean
total daily
dose (TDD) of
insulin of 97
units, where
the MDI group
used a mean
TDD of 122
units of insulin
(P<0.0001).
There was no
significant
body weight
difference
between the
groups.

This study was
conducted to
identify the
metabolic and
psychosocial
impact on
children and
adults with the
use of CSII
therapy.

The study
findings proved
that CSII
therapy was
associated with
improved
glycemic control
when compared
to MDI therapy.
Also, it was
found that the
utilization of
CSII therapy
was not
associated with
any adverse

As this was
a metaanalysis
there were
52 studies
included in
the analysis
with a total
of 1,557
subjects
with T1DM,
adult and
pediatric.

Meta-analysis

Grade
Level I;
Evidence
from a
systematic
review

Primary

Key Words:
T1DM, T2DM,
CSII therapy,
MDI therapy,
glycemic
control,
hypoglycemia,
insulin
resistance,
psychosocial,

Conclusions exhibited through
this study was that CSII
therapy is correlated with
improvement in glycemic
control, thus providing
additional support in
preventing chronic conditions
associated with diabetes.
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2016

behavior.

This study was
conducted to
compare
fluctuations in
blood glucose
levels in
T2DM
participants
treated with
three different
therapies; CSII
therapy, MDI3
(3 injections
daily), and
MDI4 (4
injections
daily).

CSII therapy
proved to
promote the
most improved
glycemic control
faster than MDI
therapy (4.26 +
1.88 days) in the
CSII group
versus (6.17 +
2.36 days)
MDI3 group,
and (581 + 2.46
days) MDI4
group. CSII
group (P < 0.05)
versus MDI3
and MDI4
groups. Also,
the longstanding
T2DM group
fared better on
CSII therapy
versus MDI3/4
therapy (P <
0.05) for CSII
group.

T2DM
patients
newly
diagnosed
and
longstandin
g T2DM,
age 18-80,
with HbA1c
of 12%,
male/female
.

Randomized,
parallel group
trial.

This study was
performed to
identify the
relationship
between users’
contact hours
in educational
program and
self-care
knowledge
variables in the
relation to
diabetes
mellitus.

A final group
of 151 users
were included
in the study. It
was found that
there was
significant
improvement
in self-care
scores
(P<0.05) for
those users
during the
educational
interventions,
which

Type 2 DM
patients,
male/female
, ages 30-85.

Longitudinal
descriptive
study

Secondary

Key words:
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Level II;
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Grade
Level VI;
Evidence
from a single
descriptive
study

MDI therapy,
CSII therapy,
Insulin pump,
Behavior,
T2DM, T1DM,
glycemic control

This study focuses on the
improvement in glycemic
control with the use of CSII
therapy in T2DM patients
who are not controlled on
MDI therapy. Unfortunately,
further study is needed to
examine the risks of CSII
therapy focusing on the
psychological impact of
utilizing this technology,
along with future
advancements associated with
the technology and patient
adherence

Secondary

Keywords:
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knowledge, selfcare, nursing.

This study highlights the
benefits of patient education
and the promotion of self-care
and knowledge enhancement
and understanding of diabetes.
It is interesting to note that the
151 participants in this study
gained improvement in both
self-care qualities (P<0.05),
as well as baseline knowledge
at the conclusion of the
educational program.
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This study was
performed to
analyze the
efficacy of
improving
disease
management
after
implementing a
selfmanagement
program for
people with
T2DM.

There were (n
= 147)
participants in
the
experimental
group and (n =
81) in the
control group.
Post test
scores of BMI
(P < 0.01),
waistline
circumference
(P< 0.01),
Hba1c
(P<0.001) and
depression/anx
iety
(P<0.001)in
the
experimental
group versus
the control
group. Posttest scores for
self-efficacy
(P,0.001) for
the
experimental
group.

T2DM,
male/female
, > 20 years
of age.

The purpose of
this study was
to examine the
published

There was a
large variance
in the studies
and their

Sixteen
intervention
randomized
controlled

Quasiexperimental
design

Secondary

Keywords:
Grade
Level III

Systematic
Review

T2DM, selfmanagement,
self-care,
education,

This study highlights that
people living with diabetes
can effectively improve selfefficacy with planned
implementation of selfmanagement training
programs with trained
healthcare workers. This
illustrates that with continued
diabetes education promoting
self-care habits and
understanding, improvement
in factors associated with
diabetes and the chronicity of
the disease can be reduced,
thus reducing risk factors for
multiple other complications
associated with diabetes.
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This systematic review
focused on educational
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literature on
the effect of
problemsolving
interventions
on diabetes
selfmanagement
and disease
control.

approaches to
problemsolving in
patient
education. It
was found,
however, that
with education
regarding
problemsolving
interventions
36% of the
adults who
participate in
the study and
42% of
children who
participated in
the study
showed
significant
improvement
in HbA1c.
Psychosocial
outcomes have
been more
promising.

trials (11
adults, 5
children/ado
lescent) and
8
intervention
studies that
were quasiexperimenta
l designs (6
adult, 2
children/ado
lescent)
consisting
of
T1DM/T2D
M,
Male/female

This study was
looking at
barriers/influen
ces that
influence selfmanagement/se
lf-care for
adults with
types 1 and 2
diabetes
mellitus

In this
systematic
review there
were multiple
barriers that
were
associated
with the dayto-day
management
of diabetes.
The key issues
related to
communicatio
n, education,
personal
factors,
providers’
issues.
Interestingly,
communicatio
n with

Adults
living with
types 1 and
2 diabetes
mellitus.
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focus, decision
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interventions and the positive
aspects associated with the
use of patient education as a
positive intervention in
improving glycemic control,
and promoting selfmanagement/self-care
attributes. With continued
patient education, chronic
conditions associated with
uncontrolled diabetes can be
reduced, allowing patients to
feel empowered over the
course of their diagnosis of
diabetes.
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This study focuses on the
importance of diabetes
education concentrating on
self-care. It also highlights the
importance of communication
between provider and patient,
as well as the provision of
culturally sensitive care. With
good communication between
the provider and patient,
patient compliance will
improve It is important to
understand that this study also
find that community support
played a significant role in
patient’s ability to selfmanage their diabetes, as there
are many issues patients face
day-to-day, compounded with
vulnerability increasing
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providers,
along with
educational
programs that
provided
appropriate
skills to be
successful in
self-care was a
significant
barrier, along
with the
provision of
culturally
sensitive care

situational, cultural and social
issues. Diabetes is variable,
affecting each person
differently and as such, selfcare needs to be individually
addressed meeting each
persons’ life experiences.

